ArticleWorld journal of oncology2022

Advanced Stage Is a Risk for Severe Neutropenia in Breast Cancer Patients Undergoing Neoadjuvant Adriamycin/Cyclophosphamide/Docetaxel Chemotherapy.

Kazuki Moro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.